Len Mistretta is the CEO and president of a well-recognized supplement industry named Nexpharma. Len Mistretta began his first business at the age of 15.Len Mistretta has mission is to provide our customers with premium sports supplements and nutritional health products.Len Mistretta's company provides free shipping of nutrition and sport supplement in North America.
Tuesday, 4 October 2016
Saturday, 3 September 2016
Len Mistretta | Role of Pharmacy in Public Health
The expression Pharmacy has been begun from the root word Pharma that is the learning and technique of assembling and additionally organization of medications. This is a well-being calling and it contacts well-being sciences by compound sciences and means to make certain the protected and also significant activity of Pharmaceutical medications. The scope of Pharmacy activity incorporates more conventional parts, for example, intensifying and administering meds, and it additionally involves additional state-of-the-art administrations connected to social insurance, including clinical administrations, assessing solutions for security and viability, and giving medication data. Drug store is a standout among the most fiscally remunerating professions and it joins science, medicinal services, PC innovation, business, math and directing. Again and again, jobs in the sciences connect with halfway relations with the group; however Pharmacy introduces an irregular balance of freedom and dealings with customers that might be prepared to do amazingly satisfying for grassroots or people. The Pharmacy is fit for a staggeringly invigorating occupation and this jelly proffer a considerable measure of propelling chances all through the time of an entire calling.
The subject of Pharmacy can regularly be arranged into the three most imperative orders
1. Pharmaceutics
2. Restorative Chemistry and Pharmacology
3. Drug store Practice
The outskirts including in the middle of these orders and by different sciences, for example Biochemistry, are not in any way times direct. Over and again, joint gatherings from an assortment of orders (Pharmacists and different Scientists) can drudge by and large to introduce of most recent techniques and therapeutics for consideration of patients.On the other hand, Pharmacy does not have a place a key or else biomedical order in its unmistakable structure. Restorative Chemistry, without anyone else, is also a discrete subdivision of study of Synthetic Chemistry joining Chemical Biology, Organic Chemistry and Pharmacology. Periodically, Pharmacology is trusted like the fourth teach of Pharmacy. Despite the fact that to investigation of Pharmacy, Pharmacology is vital, yet it is not unequivocal to Pharmacy and both are separate controls. People who yearning to practice Pharmacology (a biomedical science requiring the experimental strategy) and Pharmacy (understanding focused) similarly, need to captivate preparing and degrees sole to either train independently. Pharmacy-information (additionally alluded to as Pharmacy Information) is thought an alternate imaginative order for efficient medication innovation and extension by method for adequacy and prosperity.
Thursday, 1 September 2016
Some Reasons Teens Abuse Alcohol or Drugs | Len Mistretta
It’s a weak time of life as teen’s
effort to navigate the unsafe bridge among childhood and adulthood. And one of
the most complicated decisions, for an age group that’s ill-ready to make
difficult choices, is whether to start utilizing alcohol or drugs. Here are the
some reason Teen Abuse Alcohol and drugs
Peer pressure
Peer pressure is an effective force at any level of life, but
it’s particularly powerful throughout teenage life. At a time when children are
trying to shape out which they are and where they fit in –when worries can be
fierce – the wish to be approved and liked makes saying “no” extremely
difficult. Saying no can also have distressing consequences, ranging from being
laughed at or slightly teased, to being humiliated, refused, and even bullied.
Modeling parents’ behavior
Teens that
develop up with parents who neglect alcohol or drugs often follow suit. After
all, that’s what they know and what they’ve acquired. Not to mention, if one or
both mom and dad are definitely utilizing they frequently have easy
accessibility as well. Not only does the apple frequently not fall far from the
tree, children often mimic their parents’ actions – both good and bad.
Granted, some children will do the very reverse and
shun all substances, wanting to prevent the very thing that ruined their
parents’ lives or led to traumatic childhood activities, such as punishment or
ignore.
Curiosity
Curiosity
not only “killed the cat,” it also can be a very desirable temptress. The wish
to try new issues and examine the world didn’t instantly shut off when
adolescence commenced. In fact, it frequently turns into even stronger. Most teenagers have a lot more
independence (and some have way too much) than they did as kids. They’re fewer
closely monitored and frequently left home alone for sections of time while mom
and dad are still at work or out for the night time.
Rebellion
Teens like
to claim their budding adulthood and test the limits with their parents. Those
with irritating, overprotective, or strict parents normally lash out in a
passive-aggressive way. As per Instead of talking to mom and dad
about their worries, such as what they understand as overly strict rules,
religious hypocrisy, or constant irritating, they may insurgent by using
alcohol or drugs — especially if they know that doing so will develop their
parents upset or shy.
Tuesday, 30 August 2016
New Solutions to Support a Pharmaceutical Value Chain that is in Flux | Len Mistretta
Time to market continues to be crucial. Developing processes that can
be up and running quickly, enable fast changeovers, and reformulation
as needed, can make the difference between success and failure in this
fast-paced market.
Contract manufacturing can provide an effective approach to get
production running quickly. The pharmaceutical industry has witnessed a
shift from a vertically integrated business model to a network of
suppliers. Contract manufacturing has evolved as one of the integral
components of the pharmaceutical supply chain. The current marketplace
has numerous established and emerging companies that can manufacture new
products, offering a diverse collection of services. The scale of
operation varies from manufacturing for clinical trials to full
production. Contract manufacturing includes active pharmaceutical
ingredient and finished dosage forms manufacturing. Contract
manufacturing can also encompass packaging.
Another trend is the emergence of single-use disposable
manufacturing. It is easy to imagine single use for filters or tubing
systems but, today, even buffer containers and bioreactors are single
use. Entire disposable facilities are also possible today at a fraction
of the cost of traditional stainless steel manufacturing facilities.
Manufacturing production that has to be up and running quickly, such as
for a vaccine for a pandemic, often uses disposables.
China, India and other countries are rapidly developing domestic
pharmaceutical, bio pharmaceutical, and generic drug industries. Due to
increasing cost pressure and increased local demand, global
pharmaceutical companies are locating production to emerging markets. Read More.....
Thursday, 25 August 2016
Centre Directs Pharmaceutical Companies to Self Govern on Quality | Len Mistretta
All pharmaceutical companies will have to submit a self assessment and quality rating based on global standards. It is aimed at creating more transparency and increasing the responsibility of the pharmaceutical companies. The Central government has made it mandatory for all pharmaceutical companies to submit a self assessment and quality rating based on global standards in a bid to curb the sale of spurious and substandard drugs.
DRUGS AND COSMETICS ACT REVAMPED
In a major revamp of Drugs and Cosmetics
Act, 1940, the Central Drugs Standard Control Organization (CDSCO) under
Union Health Ministry has prepared a detailed checklist for all
manufacturing facilities. They will now have to comply with the
requirements of Good Manufacturing Practices (GMP) and Good Laboratory
Practices (GLP) as specified under Drugs and Cosmetics Rules. The checklist prepared by CDSCO also
includes World Health Organisation (WHO) GMP and Pharmaceutical
Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
(PIC/S) standards. "The tool has been devised with a view to ensure that
each pharmaceutical manufacturing unit also carries out
self-assessment," said Dr G N Singh, Drugs Controller General (India).
AIMS AT TRANSPARENCY AND INCREASED RESPONSIBILITY OF PHARMA COMPANIES
We aim to end license raj in the
country. We want to device a transparent system in which there are
stricter rules and punishment. Pharmaceutical companies would be more
responsible with this system and there will be an improvement in the
quality of drugs," said Dr Singh.
According to government's own surveys, there are a considerable number of substandard drugs thriving in the country. Based on the samples taken by CDSCO during 2011-12 to 2014-15 (up to September, 2014), 3.33 per cent samples were found to be not of standard quality. Read More....
According to government's own surveys, there are a considerable number of substandard drugs thriving in the country. Based on the samples taken by CDSCO during 2011-12 to 2014-15 (up to September, 2014), 3.33 per cent samples were found to be not of standard quality. Read More....
Tuesday, 23 August 2016
Len Mistretta | A Guide to Digital Experience Management for Healthcare and Pharmaceutical Companies
Digital experience management (DXM) refers to the marshaling of
strategy, process, and technology to provide highly satisfying digital
interactions to customers. DXM is relevant across industries, but it has
a special place in the healthcare industry--so much so that I'd like to
think of it as the digital equivalent of the mandate to "wash your
hands." In other industries serving to enhance customer interactions,
DXM is the icing on the cake. But in the healthcare realm, DXM can play
an even more crucial role in helping achieve better health outcomes for
customers. This article focuses on DXM for organizations in the
healthcare industry-hospital systems and other healthcare providers,
pharmaceutical companies, and medical device makers.
The
healthcare industry is heavily regulated globally and is not an early
adopter of digital technologies and techniques, including DXM. But
consumers, exposed to superior digital experiences in other industries
(such as retail and financial services), have increasingly high
expectations of healthcare companies.
As more of the healthcare
value chain gets digitized, the importance of DXM is only going to
increase. Similar to other industries, a good web presence and useful
mobile apps are table stakes for the healthcare industry. Beyond that,
here are specific healthcare DXM considerations to help you rise above
the fray. READ MORE.....
Monday, 22 August 2016
Medivation shares pop after report that at least five companies interested in deal | Len Mistretta
Shares of Medivation
briefly popped more than 4 percent Wednesday after a report that at
least five pharmaceutical companies expressed interest in buying the
bio pharmaceutical company.
The stock later pared its gains and ended the day up about 2 percent.
Merck is one of five pharmaceutical companies who have expressed interest in buying Medivation, according to Reuters, citing sources who asked not be identified because the sale process details are confidential.
The other companies listed are: Sanofi, Pfizer, Celgene and Gilead Sciences.
For the past several months, reports have surfaced of drug makers approaching Medivation to express interest in an acquisition. Read More....
Merck is one of five pharmaceutical companies who have expressed interest in buying Medivation, according to Reuters, citing sources who asked not be identified because the sale process details are confidential.
The other companies listed are: Sanofi, Pfizer, Celgene and Gilead Sciences.
For the past several months, reports have surfaced of drug makers approaching Medivation to express interest in an acquisition. Read More....
Saturday, 13 August 2016
Glenmark Pharmaceuticals' Q1 net profit up 24% at Rs 227 cr | Len Mistretta
New Delhi, Aug 12 () Glenmark Pharmaceuticals
today reported a 23.96 per cent rise in consolidated net profit to Rs
226.78 crore for the first quarter ended June 30, 2016, mainly on
account of robust sales.
The company had reported a net profit after tax, minority interest and share of profit of associates of Rs 182.94 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a BSE filing.
Consolidated total income from operations of the company also rose to Rs 1,943.05 crore as against Rs 1,647.74 crore for the year-ago period.
Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said: "In the first quarter of this financial year, nearly all our businesses have rebounded strongly and we have seen good growth across all operating regions except Latam."
The US business continues to perform well and the recent approvals for the business will ensure that the growth momentum continues, he added.
About other markets, Saldanha said: "The Europe business performed well due to strong growth witnessed by the UK subsidiary. The ROW region also rebounded strongly due to a solid performance by the Russian business." Read more.......
The company had reported a net profit after tax, minority interest and share of profit of associates of Rs 182.94 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a BSE filing.
Consolidated total income from operations of the company also rose to Rs 1,943.05 crore as against Rs 1,647.74 crore for the year-ago period.
Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said: "In the first quarter of this financial year, nearly all our businesses have rebounded strongly and we have seen good growth across all operating regions except Latam."
The US business continues to perform well and the recent approvals for the business will ensure that the growth momentum continues, he added.
About other markets, Saldanha said: "The Europe business performed well due to strong growth witnessed by the UK subsidiary. The ROW region also rebounded strongly due to a solid performance by the Russian business." Read more.......
Subscribe to:
Posts (Atom)